The Implication of Platelet Activating Factor in Cancer Growth and Metastasis: Potent Beneficial Role of PAF-Inhibitors and Antioxidants

Publisher： Bentham Science Publishers

E-ISSN： 2212-3989|9|4|390-399

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.9, Iss.4, 2009-08, pp. : 390-399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet-Activating Factor (PAF) Antagonists Attenuate Inflammatory- Based Pain: Potential Cellular and Anatomical Sites of PAF Action

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 2, 2006-01 ,pp. : 129-133

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist

By Albert D.H.   Magoc T.J.   Tapang P.   Luo G.   Morgan D.W.   Curtin M.   Sheppard G.S.   Xu L.   Heyman H.R.   Davidsen S.K.   Summers J.B.   Carter G.W.  

European Journal of Pharmacology, Vol. 325, Iss. 1, 1997-04 ,pp. : 69-80

Elsevier

Access to resources Recommend Favorite

Platelet Activating Factor (PAF) Antagonistic Activities of Compounds Isolated from Guttiferae Species

By bin Jantan Ibrahim   Jalil Juriyati   Abd. Warif Nor Malia  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 39, Iss. 4, 2001-08 ,pp. : 243-246

Informa Healthcare

Access to resources Recommend Favorite

Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum

By Nordin Noraziah   Jalil Juriyati   Jantan Ibrahim   Murad Shahnaz  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 50, Iss. 3, 2012-03 ,pp. : 284-290

Informa Healthcare

Access to resources Recommend Favorite

Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A 2 inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazines

By Binisti C.   Assogba L.   Touboul E.   Mounier C.   Huet J.   Ombetta J.-E.   Dong C.Z.   Redeuilh C.   Heymans F.   Godfroid J.-J.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 10, 2001-10 ,pp. : 809-828

Elsevier

Access to resources Recommend Favorite